FDMT vs PG
4D Molecular Therapeutics Inc (FDMT) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
FDMT currently screens at market cap $518.1M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the FDMT and PG stock pages for the full models.
Not investment advice.